The Latest Headlines at American Banking and Market News
Q2 2024 EPS Estimates for TKO Group Holdings, Inc. (NYSE:TKO) Increased by Analyst
TKO Group Holdings, Inc. (NYSE:TKO – Free Report) – Equities research analysts at Seaport Res Ptn upped their Q2 2024 earnings estimates for shares of TKO Group in a research report issued to clients and investors on... More of this article »
Q2 2024 Earnings Forecast for Tango Therapeutics, Inc. Issued By Leerink Partnrs (NASDAQ:TNGX)
Tango Therapeutics, Inc. (NASDAQ:TNGX – Free Report) – Equities research analysts at Leerink Partnrs dropped their Q2 2024 earnings estimates for Tango Therapeutics in a report issued on Wednesday, May 8th. Leerink... More of this article »
Q2 2024 EPS Estimates for Tango Therapeutics, Inc. (NASDAQ:TNGX) Decreased by Wedbush
Tango Therapeutics, Inc. (NASDAQ:TNGX – Free Report) – Equities researchers at Wedbush cut their Q2 2024 earnings per share estimates for Tango Therapeutics in a report issued on Thursday, May 9th. Wedbush analyst R.... More of this article »
Q2 2024 EPS Estimates for Entrada Therapeutics, Inc. Increased by HC Wainwright (NASDAQ:TRDA)
Entrada Therapeutics, Inc. (NASDAQ:TRDA – Free Report) – Equities researchers at HC Wainwright upped their Q2 2024 earnings per share (EPS) estimates for Entrada Therapeutics in a note issued to investors on Wednesday,... More of this article »
Q2 2024 Earnings Forecast for 2seventy bio, Inc. Issued By Wedbush (NASDAQ:TSVT)
2seventy bio, Inc. (NASDAQ:TSVT – Free Report) – Research analysts at Wedbush lifted their Q2 2024 earnings per share (EPS) estimates for 2seventy bio in a report released on Wednesday, May 8th. Wedbush analyst D. Nierengarten... More of this article »
TELUS Co. (NYSE:TU) to Post Q2 2024 Earnings of $0.15 Per Share, Desjardins Forecasts
TELUS Co. (NYSE:TU – Free Report) (TSE:T) – Equities research analysts at Desjardins decreased their Q2 2024 EPS estimates for TELUS in a research note issued on Thursday, May 9th. Desjardins analyst J. Dubreuil now... More of this article »-logo-1200x675.jpg&w=240&h=220&zc=2){kind=logo}
Q2 2024 EPS Estimates for Titan International, Inc. Reduced by Analyst (NYSE:TWI)
Titan International, Inc. (NYSE:TWI – Free Report) – Equities researchers at Zacks Small Cap lowered their Q2 2024 earnings estimates for shares of Titan International in a report issued on Wednesday, May 8th. Zacks... More of this article »
Analysts Issue Forecasts for Union Pacific Co.’s Q2 2024 Earnings (NYSE:UNP)
Union Pacific Co. (NYSE:UNP – Free Report) – Equities researchers at Zacks Research upped their Q2 2024 earnings per share (EPS) estimates for shares of Union Pacific in a research report issued on Thursday, May 9th.... More of this article »
U.S. Physical Therapy, Inc. (NYSE:USPH) Forecasted to Earn Q2 2024 Earnings of $0.74 Per Share
U.S. Physical Therapy, Inc. (NYSE:USPH – Free Report) – Equities research analysts at William Blair upped their Q2 2024 EPS estimates for shares of U.S. Physical Therapy in a note issued to investors on Wednesday, May... More of this article »
Valneva SE (NASDAQ:VALN) Expected to Post Q2 2024 Earnings of ($0.47) Per Share
Valneva SE (NASDAQ:VALN – Free Report) – HC Wainwright cut their Q2 2024 earnings per share (EPS) estimates for Valneva in a report issued on Wednesday, May 8th. HC Wainwright analyst E. White now expects that the company... More of this article »
Q2 2024 Earnings Estimate for Vericel Co. Issued By HC Wainwright (NASDAQ:VCEL)
Vericel Co. (NASDAQ:VCEL – Free Report) – HC Wainwright decreased their Q2 2024 earnings per share (EPS) estimates for shares of Vericel in a research note issued to investors on Thursday, May 9th. HC Wainwright analyst... More of this article »
Q2 2024 EPS Estimates for Vericel Co. Lifted by Leerink Partnrs (NASDAQ:VCEL)
Vericel Co. (NASDAQ:VCEL – Free Report) – Investment analysts at Leerink Partnrs increased their Q2 2024 earnings per share estimates for Vericel in a research report issued to clients and investors on Wednesday, May... More of this article »
Vera Therapeutics, Inc. Forecasted to Earn Q2 2024 Earnings of ($0.57) Per Share (NASDAQ:VERA)
Vera Therapeutics, Inc. (NASDAQ:VERA – Free Report) – Equities research analysts at Lifesci Capital issued their Q2 2024 earnings per share (EPS) estimates for Vera Therapeutics in a research report issued to clients... More of this article »